• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    LivaNova PLC - Ordinary Shares (NQ:LIVN)

    80.68 +2.10 (+2.67%)
    Streaming Delayed Price Updated: 11:06 AM EDT, Aug 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 160,903
    Open 77.95
    Bid (Size) 80.43 (100)
    Ask (Size) 80.83 (100)
    Prev. Close 78.58
    Today's Range 76.72 - 80.99
    52wk Range 48.78 - 85.76
    Shares Outstanding 49,023,767
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    LivaNova Q2 Earnings Call Highlights ↗
    LivaNova (NASDAQ:LIVN) reported record quarterly revenue and adjusted earnings per share for the second quarter of 2026, citing double-digit reported growth across its Cardiopulmonary and Epilepsy... 
    Via MarketBeat
    Topics Earnings World Trade
    LivaNova (NASDAQ:LIVN) Beats Q2 Earnings Estimates and Raises Full-Year Guidance ↗
    Via Chartmill

    Performance

    YTD
    +33.0%
    +33.0%
    1 Month
    -2.8%
    -2.8%
    3 Month
    +12.4%
    +12.4%
    6 Month
    +20.9%
    +20.9%
    1 Year
    +62.8%
    +62.8%

    More News

    Read More
    News headline image
    LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance
    From LivaNova PLC
    Via Business Wire
    LivaNova (NASDAQ:LIVN): A Strong Growth Stock with a Constructive Technical Setup ↗
    Via Chartmill
    LivaNova (NASDAQ:LIVN) Fits the Affordable Growth Profile with Strong Earnings and Relative Value ↗
    Via Chartmill
    LivaNova Plc (NASDAQ:LIVN) combines fundamental strength and technical timing for a potential breakout. ↗
    Via Chartmill
    LivaNova PLC (NASDAQ:LIVN) Beats Q1 Estimates, Lifts Full-Year Guidance ↗
    Via Chartmill
    LivaNova (NASDAQ:LIVN) Beats Q4 Estimates, Provides Steady 2026 Outlook ↗
    Via Chartmill
    News headline image
    LivaNova to Announce Second-Quarter 2026 Results
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea
    From LivaNova PLC
    Via Business Wire
    News headline image
    Jette Nygaard-Andersen Joins LivaNova Board as a New Director
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova Appoints Anne Liddy as Chief Legal Officer
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Present at Goldman Sachs Global Healthcare Conference in June
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova (LIVN) Q1 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    LivaNova (LIVN) Q2 2025 Earnings Transcript ↗
    Via The Motley Fool
    Topics Supply Chain
    News headline image
    LivaNova (LIVN) Q3 2025 Earnings Transcript ↗
    Via The Motley Fool
    Topics World Trade
    News headline image
    LivaNova (LIVN) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance
    From LivaNova PLC
    Via Business Wire
    News headline image
    Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Announce First-Quarter 2026 Results
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova (LIVN) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings World Trade
    News headline image
    LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results
    From LivaNova PLC
    Via Business Wire

    Frequently Asked Questions

    Is LivaNova PLC - Ordinary Shares publicly traded?
    Yes, LivaNova PLC - Ordinary Shares is publicly traded.
    What exchange does LivaNova PLC - Ordinary Shares trade on?
    LivaNova PLC - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for LivaNova PLC - Ordinary Shares?
    The ticker symbol for LivaNova PLC - Ordinary Shares is LIVN on the Nasdaq Stock Market
    What is the current price of LivaNova PLC - Ordinary Shares?
    The current price of LivaNova PLC - Ordinary Shares is 80.68
    When was LivaNova PLC - Ordinary Shares last traded?
    The last trade of LivaNova PLC - Ordinary Shares was at 08/12/26 11:06 AM ET
    What is the market capitalization of LivaNova PLC - Ordinary Shares?
    The market capitalization of LivaNova PLC - Ordinary Shares is 3.96B
    How many shares of LivaNova PLC - Ordinary Shares are outstanding?
    LivaNova PLC - Ordinary Shares has 4B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.